American Journal of Clinical Nutrition, Vol 68, 1426S-1430S, Copyright © 1998 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Genistein induces maturation of cultured human breast cancer cells and prevents tumor growth in nude mice

AI Constantinou, AE Krygier and RR Mehta
Department of Surgical Oncology, College of Medicine, University of Illinois at Chicago, 60612, USA. andreasc@uic.edu

Results of recent studies in animal models of mammary carcinogenesis showed that the soybean isoflavone genistein is a chemopreventive agent. The objective of the present study was to determine whether soybean isoflavones can be used for the prevention of human breast carcinogenesis. Human adenocarcinoma cells that are either estrogen- receptor positive (such as MCF-7) or estrogen-receptor negative (such as MDA-MB-468) were used as our model system. Treatment of these cells with genistein concentrations of 15, 30, and 45 micromol/L resulted in cell growth inhibition, which was accompanied by the expression of maturation markers. Maturation was monitored by the induction of intracytoplasmic casein and lipids and the membrane protein intercellular adhesion molecule-1. These maturation markers were optimally expressed after 9 d of treatment with 30 mmol genistein/L. Both estrogen receptor-positive and -negative cells became differentiated in response to genistein treatments, suggesting that the antiestrogenic function of genistein is unrelated to the mechanism of cell differentiation. Daidzein, the other major isoflavone component of soybeans, did not induce differentiation in either MCF-7 or MDA-MB-468 cells. To explore the potential applications of this result, we used the nude mouse xenograft model of carcinogenesis. Treatment of either cell line with genistein before implantation into nude mice diminished the cells' tumorigenic potential. These data suggest that initiation of the differentiation program provides a protective effect against tumor growth in mouse xenografts.

This article has been cited by other articles:

				C. Duffy, K. Perez, and A. Partridge Implications of Phytoestrogen Intake for Breast Cancer CA Cancer J Clin, September 1, 2007; 57(5): 260 - 277. [Abstract] [Full Text] [PDF]

				S. Rice and S. A Whitehead Phytoestrogens and breast cancer -promoters or protectors? Endocr. Relat. Cancer, December 1, 2006; 13(4): 995 - 1015. [Abstract] [Full Text] [PDF]

				D. Bentrem, J. E. Fox, S. T. Pearce, H. Liu, S. Pappas, D. Kupfer, J. W. Zapf, and V. C. Jordan Distinct Molecular Conformations of the Estrogen Receptor {alpha} Complex Exploited by Environmental Estrogens Cancer Res., November 1, 2003; 63(21): 7490 - 7496. [Abstract] [Full Text] [PDF]

				S. Wang, V. L. DeGroff, and S. K. Clinton Tomato and Soy Polyphenols Reduce Insulin-Like Growth Factor-I-Stimulated Rat Prostate Cancer Cell Proliferation and Apoptotic Resistance In Vitro via Inhibition of Intracellular Signaling Pathways Involving Tyrosine Kinase J. Nutr., July 1, 2003; 133(7): 2367 - 2376. [Abstract] [Full Text] [PDF]

				W. Miltyk, C. N Craciunescu, L. Fischer, R. A Jeffcoat, M. A Koch, W. Lopaczynski, C. Mahoney, R. A Jeffcoat, J. Crowell, J. Paglieri, et al. Lack of significant genotoxicity of purified soy isoflavones (genistein, daidzein, and glycitein) in 20 patients with prostate cancer Am. J. Clinical Nutrition, April 1, 2003; 77(4): 875 - 882. [Abstract] [Full Text] [PDF]

				C.-L. Sun, J.-M. Yuan, K. Arakawa, S.-H. Low, H.-P. Lee, and M. C. Yu Dietary Soy and Increased Risk of Bladder Cancer: the Singapore Chinese Health Study Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1674 - 1677. [Abstract] [Full Text] [PDF]

				L. T Bloedon, A R. Jeffcoat, W. Lopaczynski, M. J Schell, T. M Black, K. J Dix, B. F Thomas, C. Albright, M. G Busby, J. A Crowell, et al. Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women Am. J. Clinical Nutrition, November 1, 2002; 76(5): 1126 - 1137. [Abstract] [Full Text] [PDF]

				Z. Jin and R. S. MacDonald Soy Isoflavones Increase Latency of Spontaneous Mammary Tumors in Mice J. Nutr., October 1, 2002; 132(10): 3186 - 3190. [Abstract] [Full Text] [PDF]

				K. D. R. Setchell Soy Isoflavones--Benefits and Risks from Nature's Selective Estrogen Receptor Modulators (SERMs) J. Am. Coll. Nutr., October 1, 2001; 20(90005): 354S - 362. [Abstract] [Full Text]

				H. You, W. Yu, B. G. Sanders, and K. Kline RRR-{alpha}-Tocopheryl Succinate Induces MDA-MB-435 and MCF-7 Human Breast Cancer Cells to Undergo Differentiation Cell Growth Differ., September 1, 2001; 12(9): 471 - 480. [Abstract] [Full Text] [PDF]

				P. Diel, K. Smolnikar, T. Schulz, U. Laudenbach-Leschowski, H. Michna, and G. Vollmer Phytoestrogens and carcinogenesis--differential effects of genistein in experimental models of normal and malignant rat endometrium Hum. Reprod., May 1, 2001; 16(5): 997 - 1006. [Abstract] [Full Text] [PDF]